Newsroom - Page 6

The top stories in managed care included the Supreme Court declining to rule on the contraception case Zubik v Burwell, Oklahoma and Louisiana both move toward expanding Medicaid, and the price of the opioid overdose drug naloxone has increased 17-fold over 2 years.
Men and women diagnosed with colorectal cancer who were class I obese had the lowest risk of dying due to their cancer, according to a new study published in JAMA Oncology.
The sequence of events that led to Thursday's complaint points to a coordinated effort to challenge Myriad Genetics' long-held position that it does not share information on public databases.
Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
A microchip sensor that can measure specific volatile compounds in the breath of those with lung cancer, is being developed by research groups in the United States and in Britain.
Primary medication nonadherence is a widespread public health problem; however, the subject lacks standardized definitions and measures.
Value, cost, and the patient are taking center stage during the ISPOR 21st Annual International Meeting, which is being held May 21-25, 2016, in Washington, DC.
What we're reading, May 20, 2016: For the third time the FDA delayed a rule about generic drug labeling; 10 years ago a government report warned of a prison health crisis, but was blocked from publication; and Oklahoma lawmakers pass a bill making it a felony to perform an abortion.
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium
HF Compendium